Form 4: NRC Health Director Receives Equity Award

NRC Health Director Penny Ann Wheeler was granted restricted stock units valued at $150,000, vesting in 2027.

Summary

• Penny Ann Wheeler, a Director at NRC Health, received an equity award on June 23, 2026.
• The award consists of restricted stock units (RSUs) valued at $150,000.
• The number of RSUs granted is calculated by dividing $150,000 by the closing stock price on the day before the Issuer's 2026 annual meeting.
• These RSUs are part of the Issuer's 2025 Omnibus Incentive Plan.
• The award is subject to vesting, forfeiture, and termination provisions.
• The RSUs will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents standard compensation for a director, indicating continued engagement and incentive alignment, but does not contain significant new financial or strategic information.

Positives

• Director Penny Ann Wheeler received a significant equity award, indicating continued investment in leadership and alignment with shareholder interests.
• The award is structured under the 2025 Omnibus Incentive Plan, suggesting a well-established compensation framework.
• The value of the award ($150,000) demonstrates a commitment to retaining and incentivizing key personnel.

Negatives

• The exact number of shares granted is not yet determined, as it depends on the closing stock price on a future date.
• The RSUs are subject to vesting, forfeiture, and termination provisions, meaning the full value is not immediately realized and could be lost under certain conditions.

Risks

• The value of the equity award is subject to market fluctuations in NRC Health's stock price.
• Vesting and forfeiture provisions introduce a risk that the award may not be fully realized by the recipient.
• The award is contingent on the Issuer's 2026 and 2027 annual meetings, implying potential delays or changes to the award if these meetings are impacted.

Future Outlook

The award is set to vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare technology sector to align executive interests with those of shareholders and incentivize long-term performance.

Stakeholder Impact

• Shareholders: The equity award aligns director compensation with shareholder interests, potentially incentivizing long-term value creation.
• Employees: The use of an incentive plan signals a structured approach to compensation, which can be a positive factor for employee morale and retention.
• Management: The award reinforces the role of the director and their ongoing commitment to the company's performance.

Next Steps

• The restricted stock units will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.

Key Dates

Keywords

NRC Health, Form 4, Insider Trading, Equity Award, Restricted Stock Units, Penny Ann Wheeler, Director Compensation, Omnibus Incentive Plan, SEC Filing